can you get semaglutide if you're not obese Wegovy® – A New Treatment for Obesity Semaglutide Before and After: Real

Content is educational only and not medical advice

This review aims to synthesise and compare the safety profiles of incretin-based therapies, including GLP-1 receptor agonists for Obesity and Type 2 Diabetes, by integrating clinical and mechanistic evidence and to identify evidence-based strategies for risk mitigation and safe clinical use

Small and sustainable lifestyle changes to diet, exercise, sleep, and stress may help maximize your results with Ozempic

Kosiborod MikhailNAbildstrm SteenZBorlaug BarryAButlerJRasmussenSDaviesMet al

On June 24, 2026, Novo Nordisk, a global leader in diabetes and obesity treatments, officially launched its flagship weight-loss drug Wegovy (Semaglutide) in India